HOME > ARCHIVE
ARCHIVE
- NEW PRODUCTS
March 31, 2003
- Korosho Orders Kyorin to Issue Dear-Dr Letter on Gatifloxacin
March 31, 2003
- Vision for Medical Devices Industry Announced
March 31, 2003
- REGULATORY NEWS IN BRIEF
March 31, 2003
- Notification on Safety Measures for Infusion Pumps Issued
March 31, 2003
- Cost Should Be Calculated for Each Diagnosis Group: JHA Seminar
March 31, 2003
- MEDICAL DEVICES NEWS IN BRIEF
March 31, 2003
- Korosho to Revise Priority NDA Review System around April
March 24, 2003
- Guidant Japan: Multi-link Penta Stent System
March 24, 2003
- Chuikyo Talks Will Initially Focus on Pricing of New Drugs
March 24, 2003
- DIAGNOSTIC NEWS IN BRIEF
March 24, 2003
- Korosho to Impose Tougher Conditions for GE Houses in Supplement Listing
March 24, 2003
- 20% Tax Deduction to Be Allowed for 8 Medical Devices Designed to Prevent Accidents
March 24, 2003
- WORD NEWS IN BRIEF
March 24, 2003
- Safety Assurance Activities of New Drug Organization Outlined
March 24, 2003
- Pollinosis Intensifying Competition in Market for Allergy Treatments
March 24, 2003
- JABP, JRCS Report Cost Breakdowns for Plasma Fraction Preparations
March 24, 2003
- e-Detailing Makes Drs Deepen Their Knowledge: ACNielsen Survey
March 24, 2003
- REGULATORY NEWS IN BRIEF
March 24, 2003
- Targeted Treatment Solutions Needed: IBM Business Consulting Report
March 24, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
